List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Robert G. McGregor
Shripad Gadhinglajkar
Gema Galayo
Elizabeth Galella
Michael Gamlen
Loksidh D. Ganorkar, PhD
Charlie Gans
William P. Ganzer
Carole Garcia
Sanjay Garg, M Pharm, PhD
Sanjay Garg, PhD
Juanita Garofolo
Brian Garret
William Garvey
Elizabeth Garza
Peter Gaskin
Kim Gaspar
Paolo Gatti
Todd Grant Gattoni
Ashwani Gaur
Zhihong Ge
S. Gebert
John C. Gebler
Tom Gelineau
Scott Geller
Carole Genovesi
Christopher L. Gent
George W. Gereg
Gerry Migliaccio
Sangita Ghosh
Soma Ghosh
Tapash K. Ghosh
Wilhelm Gierling
Henning Gieseler, PhD
Henning Gieseler
Michael Gietl
Siddhartha Gigoo
Benjamin K. Gill
Devinder S. Gill
Harvinder Singh Gill
Tiziana Gilli
John R. Gillis
Karen S. Ginsbury
Glen Giovannetti
F.C. Girard
Maria J. Glasgow
Benjamin Glasser
Benjamin J. Glassner
John Glover, DPA
Ed Godek
William Goebel
Sebastian Goettel
Michael Goetter
Mukesh C. Gohel, PhD
Abhijit Gokhale
Oskar Gold
Thomas B. Gold
Alan Goldhammer
Michael Goldkang
Jay M. Goldring
Jennifer Goldsmith
Ed Golla, PhD, CIH
Oscar Gonzalez
Hal Good
Chris Goodridge
Arik Gorban
Mary Ann Gorko
Karen Gorman
Michael A. Gosselin, Ph.D.
Abhijit V. Gothoskar
Uwe Gottschalk
Michael Gottsponer
Peter H. Gough
Evan Goulet
Joey Gouws
Joe Govier
Greg Gowaski
Tor Graberg
David Graham
Elizabeth Gramer
Niels Grasmeijer
Marissa Gray
Vivian Gray
John G. Grazal
Erik Greb
Robert L. Green
Paul Greenland
James C. Greenwood
Jim Greenwood
Fiona Greer
Aubrey M. Gregg
Brian Gregg
James C. Griffiths
Kristi L. Griffiths
Mark Griffiths
Moira Griffiths
Anthony Grilli
John Grinnell
Peter Groenewoud
Thomas Gronauer
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here